ventricular tachycardia storm - an atypical presentation of sarcoidosis exacerbation

Clicks: 160
ID: 245869
2009
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #40 of 63 articles by views in Medical decision making : an international journal of the Society for Medical Decision Making

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Management of ventricular tachycardia (VT) storm in a patient with an implantable cardioverter-defibrillator (ICD) is a challenging medical emergency. We describe a patient with cardiac sarcoidosis (CS) and an ICD who is admitted with VT storm. Management of VT was difficult due to resistance to multiple antiarrhythmic drugs. He responded to immunosuppressive therapy supporting active CS as the cause of his VT. This case suggests that CS may underlie some cases of refractory VT and that immunosuppressive therapy may be effective in controlling this arrhythmia.
Reference Key
vanga2009indianventricular Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Subba Reddy Vanga;James Vacek;Loren Berenbom;Dhanunjaya R. Lakkireddy
Journal Medical decision making : an international journal of the Society for Medical Decision Making
Year 2009
DOI
DOI not found
URL
http://www.ipej.org/0906/vanga.htm
Keywords
Diseases of the circulatory (Cardiovascular) system vt storm

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.